Desarrollamos rutas industriales de síntesis

En MOEHS nos esforzamos constantemente en desarrollar rutas industriales de síntesis para nuevos Ingredientes Activos bajo criterios de viabilidad comercial, industrial y propiedad intelectual.

Nuestro departamento comercial está a su disposición para actualizar cualquier detalle sobre el estado de nuestros nuevos desarrollos.

Productos en etapa de desarrollo

Product NameCAS N°Therapeutic CategoryAdditional InformationDMF / TP
EDOXABAN (**)1229194-11-9Oral anticoagulant Validation batchesDMF
ELAGOLIX (**)832720-36-2Antialgic for endometriosis diseaseLaboratory batchesTP
EMPAGLIFLOZIN (**)864070-44-0AntidiabeticValidation batchesDMF
LASMIDITAN (**)439239-90-4AntimigraineLaboratory batchesTP
LEMBOREXANT (**)1369764-02-2Insomnia treatmentLaboratory batchesTP
LEVOBUPIVACAINE HCL27262-47-1
Local Anesthetic-Antiarrhythmic Validation batchesTP
OBETICHOLIC ACID (**)459789-99-2Liver and gastrointestinal disordersLaboratory batchesTP
PATIROMER CALCIUM SORBITEX (**)1260645-52-4HyperkalemiaLaboratory batchesTP
RELUGOLIX (**)737789-87-6Advanced prostate cancerLaboratory batchesTP
REMIMAZOLAM (**)308242-62-8
SedativeLaboratory batches TP
RIMEGEPANT (**)1289023-67-1AntimigraineLaboratory batchesTP
RIVAROXABAN (**)366789-02-8
Antibleeding agent Validation batchesDMF
SITAGLIPTIN PHOSPHATE (**)654671-77-9
AntidiabeticValidation batches DMF
VILDAGLIPTIN (**)274901-16-5
AntidiabeticValidation batches DMF

Nuevos Productos en evaluación

Product NameCAS N°Brand NameTherapeutic CategoryGalenic Form
MAVACAMTEN (**)1642288-47-8Cardiovascularcapsules
VERICIGUAT (**)1350653-20-1Antihypertensivetablets

(**) Moehs is working on this compound with experimental aims, exclusively directed to obtain market authorizations of our customers’ generic medicines. We don’t intend to make any activity against any valid patent protection, as well as we will not take charge of third party actions made with the provided compound and without our knowledge against this protection.